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［Objective］ 
  Amelogenin has a hydrophilic C-terminal domain and a hydrophobic N- terminal 
domain, that exhibits strong polarity. Amelogenin is the major secretory product of 
ameloblasts in the developing teeth and is cleaved by serine proteases during the enamel 
maturation. It has been known that amelogenin plays crucial roles on the enamel 
mineralization. Recent studies suggest biological functions of amelogenin as a signaling 
molecule for the cell proliferation and differentiation. Extracted amelogenin proteins, 
which have been used in many studies, are the mixture of many different molecules, 
including cleaved fragments of amelogenin and growth factors. Therefore, purified 
full-length protein is required for clarifying the role of amelogenin.   
  The purpose of this study is to obtain recombinant human amelogenin from 
mammalian cell lines (EXPI cells), to examine the effects of recombinant human 
amelogenin on the differentiation and cell adhesion in rat ameloblast cells (HAT-7 cells) 
or mouse osteoblast cells (MC3T3-E1 cells). 
 
［Methods］ 
(1)?Construction of amelogenin and purified recombinant amelogenin 
  pAMELXv3-Myc-DDK-Histag plasmid was constructed and transfected into EXPI 
cells.  Recombinant human amelogenin, which was secreted into the culture media, was 
purified with DDK agarose beads. Characteristics of the recombinant amelogenin were 
examined with silver staining, MEM-CODE staining, and Western blotting using 
antibodies against DDK-tag, c-Myc-tag, and amelogenin. 
(2) Cell proliferation assay 
  HAT-7 cells and MC3T3E-1 cells were plated and were cultured in the presence or 
absence of recombinant human amelogenin or Emdogain® (EMD)．Final DNA 
concentration was measured by cell proliferation assay kit. 
(3) Alizarin red S staining and ALP assay 
  HAT-7 cells and MC3T3-E1 cells were cultured in osteogenic media in the presence or 
absence of recombinant human amelogenin or EMD. Cells were fixed and were stained 
with Alizarin red S for visualizing calcified nodules. Alkaline phosphatase activity was 
measured spectrophotometrically using p-nitrophenol as a colorimetric substrate. 
(4-1) Cell spreading assay 
  MC3T3-E1 cells were cultured in glass chambers coated with fibronectin, recombinant 
human amelogenin, or EMD. These cells were stained with DIOC6 and DAPI.  
(4-2) Effect of inhibitors on cell adhesion 
	 The glass plate was coated with fibronectin or recombinant human amelogenin, and 
MC3T3-E1 cells were cultured in the presence of RGD peptide or fibronectin inhibitor.  
(4-3) Immunostaining  
   Immunohistochemical analysis performed using an anti-paxillin antibody, and the 
fluorescence images were captured with confocal laser scanning microscopy.                         
 
［Results］ 
  Western blot analysis with anti-DDK, anti-c-Myc, and anti-amelogenin antibodies 
showed multiple protein bands with the molecular mass of 30 kDa, 33 kDa, and 65 kDa 
in the culture media sample of human amelogenin expressing EXPI cells. Western blot 
analysis of the affinity purified sample with these antibodies showed two bands with the 
molecular mass of 27 kDa and 54 kDa. Essentially identical bands were detected with 
silver staining and MEM-CODE stain, indicating that the method with purified by 
DDK-tag provide the high-purity full-length recombinant human amelogenin. This 
method allowed us to purify 450 µg of recombinant human amelogenin from 50 mL 
culture media of EXPI cells. 
  Recombinant human amelogenin and EMD reduced the proliferation of the HAT-7 
cells in a concentration dependent manner. A significant reduction was observed in the 
presence of 4 µg/mL recombinant human amelogenin or 100 µg/mL EMD. The calcium 
nodules and ALP activity in the HAT-7 cells were increased significantly by recombinant 
human amelogenin at a concentration of 4 µg/mL, but not by EMD.  
  Unlike HAT-7 cells, the proliferation of the MC3T3-E1 cells was accelerated by 100 
µg/mL EMD, but not by recombinant human amelogenin. The formation of calcium 
nodules and increased ALP activities in MC3T3-E1 cells were increased with relatively 
low concentrations of recombinant human amelogenin (0.001~0.01 µg/mL) and 1 µg/mL 
EMD.  However, high concentrations of recombinant human amelogenin (4 µg/mL) and 
100 µg/mL EMD decreased the formation of calcium nodules and ALP activities. 
  The effect of recombinant human amelogenin or EMD on the cell adhesion and 
spreading was examined using a confocal laser scanning microscopy. The area of the cell 
adhesion in the MC3T3-E1 cells was approximately 1.98-times on recombinant human 
amelogenin-coated glass than that on control (BSA-coated) glass. The RGD peptide and 
fibronectin inhibitor blocked recombinant human amelogenin or EMD mediated cell 
adhesion. In addition, accumulations of paxillin with the cell adhesion were observed by 
immunohistochemical analysis.  
 
［Discussion］  
  In the present study, the purification of full-length recombinant human amelogenin 
was obtained using EXPI cells and DDK-tag. The 27 kDa and 54 kDa bands of the 
purified samples are thought to be the monomer and dimer of human amelogenin, 
respectively. These data suggest that secreted amelogenin molecules form 
hetero-oligomer in the purified solutions. EMD constituted for the most part by the 
cleaved form of amelogenin lacking the C-terminus region. The C-terminus region in 
amelogenin has affected the difference of the results in biological activities between EMD 
and full-length recombinant human amelogenin. For example, the mineralizations and 
ALP activity in HAT-7 cells were increased by recombinant human amelogenin, but not 
by EMD. These results suggest important roles of the C-terminus of amelogenin for 
promoting ameloblast differentiations. Interestingly, the mineralizations of MC3T3-E1 
cells was increased by low concentrations of recombinant human amelogenin, it was 
decreased at the high concentrations.  
 Recombinant human amelogenin in this experiment had cell adhesive and spreading 
activity. The spreading of MC3T3-E1 cells on the dish coated with recombinant human 
amelogenin was associated with the accumulation of paxillin, a signal transduction 
adaptor protein in the integrin-mediated cell adhesion, and was blocked in the presence 
of RGD peptides or fibronectin inhibitors in the medium. These results strongly suggest 
that the recombinant human amelogenin promoted the cell adhesion through the 
binding with integrin. 
 
［Conclusion］ 
  The method to purify the full-length recombinant human amelogenin in large scale 
was established. Effects of recombinant human amelogenin on the cell differentiation 
and proliferation were the difference between HAT-7 cells and MC3T3-E1 cells. 
Furthermore, recombinant human amelogenin had cell adhesive and spreading activity.  
 
 
 
